Related Experiment Video
Updated: May 12, 2026

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
Effects of melatonin on salsolinol-induced prolactin secretion in goats
Tsutomu Hashizume1, Tomoyoshi Yaegashi, Jin Jin
1Faculty of Agriculture, Iwate University, Morioka 020-8550, Japan. hashi@iwate-u.ac.jp
Abstract:
The aim of the present study was to clarify the effect of melatonin (MEL) on the salsolinol (SAL)-induced release of prolactin (PRL) in goats. Female goats were kept at 20°C with 16 h of light, 8 h of darkness, and orally administered saline or MEL for 5 weeks. A single intravenous (i.v.) injection of saline (controls), SAL, thyrotropin-releasing hormone (TRH) or a dopamine receptor antagonist, sulpiride, was given to the goats 3 weeks after the first oral administrations of saline or MEL, and the responses were compared. The mean basal plasma PRL concentrations in the control group were higher for the saline treatments than MEL treatments (P < 0.05). SAL as well as TRH and sulpiride stimulated the release of PRL promptly after each injection in both the saline- and MEL-treated groups (P < 0.05). The area under the response curve of PRL for the 60-min period after the i.v. injection of SAL, TRH and sulpiride in the saline-treated group was greater than each corresponding value in the MEL-treated group (P < 0.05). These results show that daily exposure to MEL under a long day length reduces the PRL-releasing response to SAL as well as TRH and sulpiride in goats.
Related Concept Videos
Management of Insomnia
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
The Pineal Gland
The primary secretion of the pineal gland is the hormone melatonin, derived from serotonin. The concentration of melatonin in the...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
